journal
https://read.qxmd.com/read/38548985/correction-neuron-type-specific-proteomics-reveals-distinct-shank3-proteoforms-in-ispns-and-dspns-lead-to-striatal-synaptopathy-in-shank3b-mice
#21
Yi-Zhi Wang, Tamara Perez-Rosello, Samuel N Smukowski, D James Surmeier, Jeffrey N Savas
No abstract text is available yet for this article.
March 28, 2024: Molecular Psychiatry
https://read.qxmd.com/read/38548984/the-relationship-between-prefrontal-cortex-gray-matter-volume-and-subcortical-dopamine-release-an-addendum
#22
LETTER
Matthäus Willeit, Ulrich Sauerzopf, Nicole Praschak-Rieder, Ana Weidenauer
No abstract text is available yet for this article.
March 28, 2024: Molecular Psychiatry
https://read.qxmd.com/read/38548983/genome-wide-association-study-of-obsessive-compulsive-symptoms-including-33-943-individuals-from-the-general-population
#23
JOURNAL ARTICLE
Nora I Strom, Christie L Burton, Conrad Iyegbe, Talisa Silzer, Lilit Antonyan, René Pool, Mathieu Lemire, James J Crowley, Jouke-Jan Hottenga, Volen Z Ivanov, Henrik Larsson, Paul Lichtenstein, Patrik Magnusson, Christian Rück, Russell Schachar, Hei Man Wu, Danielle Cath, Jennifer Crosbie, David Mataix-Cols, Dorret I Boomsma, Manuel Mattheisen, Sandra M Meier, Dirk J A Smit, Paul D Arnold
While 1-2% of individuals meet the criteria for a clinical diagnosis of obsessive-compulsive disorder (OCD), many more (~13-38%) experience subclinical obsessive-compulsive symptoms (OCS) during their life. To characterize the genetic underpinnings of OCS and its genetic relationship to OCD, we conducted the largest genome-wide association study (GWAS) meta-analysis of parent- or self-reported OCS to date (N = 33,943 with complete phenotypic and genome-wide data), combining the results from seven large-scale population-based cohorts from Sweden, the Netherlands, England, and Canada (including six twin cohorts and one cohort of unrelated individuals)...
March 28, 2024: Molecular Psychiatry
https://read.qxmd.com/read/38548982/clinical-and-genetic-contributions-to-medical-comorbidity-in-bipolar-disorder-a-study-using-electronic-health-records-linked-biobank-data
#24
JOURNAL ARTICLE
Jorge A Sanchez-Ruiz, Brandon J Coombes, Vanessa M Pazdernik, Lindsay M Melhuish Beaupre, Greg D Jenkins, Richard S Pendegraft, Anthony Batzler, Aysegul Ozerdem, Susan L McElroy, Manuel A Gardea-Resendez, Alfredo B Cuellar-Barboza, Miguel L Prieto, Mark A Frye, Joanna M Biernacka
Bipolar disorder is a chronic and complex polygenic disease with high rates of comorbidity. However, the independent contribution of either diagnosis or genetic risk of bipolar disorder to the medical comorbidity profile of individuals with the disease remains unresolved. Here, we conducted a multi-step phenome-wide association study (PheWAS) of bipolar disorder using phenomes derived from the electronic health records of participants enrolled in the Mayo Clinic Biobank and the Mayo Clinic Bipolar Disorder Biobank...
March 28, 2024: Molecular Psychiatry
https://read.qxmd.com/read/38532012/immunophenotypes-in-psychosis-is-it-a-premature-inflamm-aging-disorder
#25
REVIEW
Song Chen, Yunlong Tan, Li Tian
Immunopsychiatric field has rapidly accumulated evidence demonstrating the involvement of both innate and adaptive immune components in psychotic disorders such as schizophrenia. Nevertheless, researchers are facing dilemmas of discrepant findings of immunophenotypes both outside and inside the brains of psychotic patients, as discovered by recent meta-analyses. These discrepancies make interpretations and interrogations on their roles in psychosis remain vague and even controversial, regarding whether certain immune cells are more activated or less so, and whether they are causal or consequential, or beneficial or harmful for psychosis...
March 26, 2024: Molecular Psychiatry
https://read.qxmd.com/read/38532011/active-forgetting-and-neuropsychiatric-diseases
#26
REVIEW
Jacob A Berry, Dana C Guhle, Ronald L Davis
Recent and pioneering animal research has revealed the brain utilizes a variety of molecular, cellular, and network-level mechanisms used to forget memories in a process referred to as "active forgetting". Active forgetting increases behavioral flexibility and removes irrelevant information. Individuals with impaired active forgetting mechanisms can experience intrusive memories, distressing thoughts, and unwanted impulses that occur in neuropsychiatric diseases. The current evidence indicates that active forgetting mechanisms degrade, or mask, molecular and cellular memory traces created in synaptic connections of "engram cells" that are specific for a given memory...
March 26, 2024: Molecular Psychiatry
https://read.qxmd.com/read/38532010/serotonin-effects-on-human-ipsc-derived-neural-cell-functions-from-mitochondria-to-depression
#27
JOURNAL ARTICLE
Iseline Cardon, Sonja Grobecker, Frederike Jenne, Tatjana Jahner, Rainer Rupprecht, Vladimir M Milenkovic, Christian H Wetzel
Depression's link to serotonin dysregulation is well-known. The monoamine theory posits that depression results from impaired serotonin activity, leading to the development of antidepressants targeting serotonin levels. However, their limited efficacy suggests a more complex cause. Recent studies highlight mitochondria as key players in depression's pathophysiology. Mounting evidence indicates that mitochondrial dysfunction significantly correlates with major depressive disorder (MDD), underscoring its pivotal role in depression...
March 26, 2024: Molecular Psychiatry
https://read.qxmd.com/read/38532009/chronometric-tms-fmri-of-personalized-left-dorsolateral-prefrontal-target-reveals-state-dependency-of-subgenual-anterior-cingulate-cortex-effects
#28
JOURNAL ARTICLE
Sarah Grosshagauer, Michael Woletz, Maria Vasileiadi, David Linhardt, Lena Nohava, Anna-Lisa Schuler, Christian Windischberger, Nolan Williams, Martin Tik
Transcranial magnetic stimulation (TMS) applied to a left dorsolateral prefrontal cortex (DLPFC) area with a specific connectivity profile to the subgenual anterior cingulate cortex (sgACC) has emerged as a highly effective non-invasive treatment option for depression. However, antidepressant outcomes demonstrate significant variability among therapy plans and individuals. One overlooked contributing factor is the individual brain state at the time of treatment. In this study we used interleaved TMS-fMRI to investigate the influence of brain state on acute TMS effects, both locally and remotely...
March 26, 2024: Molecular Psychiatry
https://read.qxmd.com/read/38532008/sex-dimorphism-controls-dysbindin-related-cognitive-dysfunctions-in-mice-and-humans-with-the-contribution-of-comt
#29
JOURNAL ARTICLE
Federica Geraci, Roberta Passiatore, Nora Penzel, Samuele Laudani, Alessandro Bertolino, Giuseppe Blasi, Adriana C E Graziano, Gianluca C Kikidis, Ciro Mazza, Madhur Parihar, Antonio Rampino, Leonardo Sportelli, Nicolò Trevisan, Filippo Drago, Francesco Papaleo, Fabio Sambataro, Giulio Pergola, Gian Marco Leggio
Cognitive dysfunctions are core-enduring symptoms of schizophrenia, with important sex-related differences. Genetic variants of the DTBPN1 gene associated with reduced dysbindin-1 protein (Dys) expression negatively impact cognitive functions in schizophrenia through a functional epistatic interaction with Catechol-O-methyltransferase (COMT). Dys is involved in the trafficking of dopaminergic receptors, crucial for prefrontal cortex (PFC) signaling regulation. Moreover, dopamine signaling is modulated by estrogens via inhibition of COMT expression...
March 26, 2024: Molecular Psychiatry
https://read.qxmd.com/read/38528071/transcriptomic-dysregulation-and-autistic-like-behaviors-in-kmt2c-haploinsufficient-mice-rescued-by-an-lsd1-inhibitor
#30
JOURNAL ARTICLE
Takumi Nakamura, Toru Yoshihara, Chiharu Tanegashima, Mitsutaka Kadota, Yuki Kobayashi, Kurara Honda, Mizuho Ishiwata, Junko Ueda, Tomonori Hara, Moe Nakanishi, Toru Takumi, Shigeyoshi Itohara, Shigehiro Kuraku, Masahide Asano, Takaoki Kasahara, Kazuo Nakajima, Takashi Tsuboi, Atsushi Takata, Tadafumi Kato
Recent studies have consistently demonstrated that the regulation of chromatin and gene transcription plays a pivotal role in the pathogenesis of neurodevelopmental disorders. Among many genes involved in these pathways, KMT2C, encoding one of the six known histone H3 lysine 4 (H3K4) methyltransferases in humans and rodents, was identified as a gene whose heterozygous loss-of-function variants are causally associated with autism spectrum disorder (ASD) and the Kleefstra syndrome phenotypic spectrum. However, little is known about how KMT2C haploinsufficiency causes neurodevelopmental deficits and how these conditions can be treated...
March 26, 2024: Molecular Psychiatry
https://read.qxmd.com/read/38528072/resting-state-functional-connectivity-modifications-in-monoaminergic-circuits-underpin-fatigue-development-in-patients-with-multiple-sclerosis
#31
JOURNAL ARTICLE
Monica Margoni, Paola Valsasina, Anna Bacchetti, Damiano Mistri, Paolo Preziosa, Maria A Rocca, Massimo Filippi
Dysregulation of monoaminergic networks might have a role in the pathogenesis of fatigue in multiple sclerosis (MS). We investigated longitudinal changes of resting state (RS) functional connectivity (FC) in monoaminergic networks and their association with the development of fatigue in MS. Eighty-nine MS patients and 49 age- and sex-matched healthy controls (HC) underwent neurological, fatigue, and RS functional MRI assessment at baseline and after a median follow-up of 1.3 years (interquartile range = 1...
March 25, 2024: Molecular Psychiatry
https://read.qxmd.com/read/38523183/oral-esketamine-in-patients-with-treatment-resistant-depression-a-double-blind-randomized-placebo-controlled-trial-with-open-label-extension
#32
JOURNAL ARTICLE
Sanne Y Smith-Apeldoorn, Jolien K E Veraart, Jeanine Kamphuis, Jan Spijker, Annemarie van der Meij, Antoinette D I van Asselt, Marije Aan Het Rot, Robert A Schoevers
About one-third of patients with depression do not achieve adequate response to current treatment options. Although intravenous and intranasal administrations of (es)ketamine have shown antidepressant properties, their accessibility and scalability are limited. We investigated the efficacy, safety, and tolerability of generic oral esketamine in patients with treatment-resistant depression (TRD) in a randomized placebo-controlled trial with open-label extension. This study consisted of 1) a six-week fixed low-dose treatment phase during which 111 participants received oral esketamine 30 mg or placebo three times a day; 2) a four-week wash-out phase; and 3) an optional six-week open-label individually titrated treatment phase during which participants received 0...
March 25, 2024: Molecular Psychiatry
https://read.qxmd.com/read/38519640/genetic-contribution-to-microglial-activation-in-schizophrenia
#33
JOURNAL ARTICLE
Marja Koskuvi, Elina Pörsti, Tristen Hewitt, Noora Räsänen, Ying-Chieh Wu, Kalevi Trontti, Amanda McQuade, Shringaa Kalyanaraman, Ilkka Ojansuu, Olli Vaurio, Tyrone D Cannon, Jouko Lönnqvist, Sebastian Therman, Jaana Suvisaari, Jaakko Kaprio, Mathew Blurton-Jones, Iiris Hovatta, Markku Lähteenvuo, Taisia Rolova, Šárka Lehtonen, Jari Tiihonen, Jari Koistinaho
Several lines of evidence indicate the involvement of neuroinflammatory processes in the pathophysiology of schizophrenia (SCZ). Microglia are brain resident immune cells responding toward invading pathogens and injury-related products, and additionally, have a critical role in improving neurogenesis and synaptic functions. Aberrant activation of microglia in SCZ is one of the leading hypotheses for disease pathogenesis, but due to the lack of proper human cell models, the role of microglia in SCZ is not well studied...
March 22, 2024: Molecular Psychiatry
https://read.qxmd.com/read/38514804/the-alzheimer-s-disease-risk-gene-bin1-regulates-activity-dependent-gene-expression-in-human-induced-glutamatergic-neurons
#34
JOURNAL ARTICLE
Orthis Saha, Ana Raquel Melo de Farias, Alexandre Pelletier, Dolores Siedlecki-Wullich, Bruna Soares Landeira, Johanna Gadaut, Arnaud Carrier, Anaïs-Camille Vreulx, Karine Guyot, Yun Shen, Amelie Bonnefond, Philippe Amouyel, Julia Tcw, Devrim Kilinc, Claudio Marcos Queiroz, Fabien Delahaye, Jean-Charles Lambert, Marcos R Costa
Bridging Integrator 1 (BIN1) is the second most important Alzheimer's disease (AD) risk gene, but its physiological roles in neurons and its contribution to brain pathology remain largely elusive. In this work, we show that BIN1 plays a critical role in the regulation of calcium homeostasis, electrical activity, and gene expression of glutamatergic neurons. Using single-cell RNA-sequencing on cerebral organoids generated from isogenic BIN1 wild type (WT), heterozygous (HET) and homozygous knockout (KO) human-induced pluripotent stem cells (hiPSCs), we show that BIN1 is mainly expressed by oligodendrocytes and glutamatergic neurons, like in the human brain...
March 22, 2024: Molecular Psychiatry
https://read.qxmd.com/read/38514803/the-nested-hierarchical-model-of-self-and-its-non-relational-vs-relational-posttraumatic-manifestation-an-fmri-meta-analysis-of-emotional-processing
#35
Andrea Scalabrini, Marco Cavicchioli, Francesco Benedetti, Clara Mucci, Georg Northoff
Different kinds of traumatic experiences like natural catastrophes vs. relational traumatic experiences (e.g., sex/physical abuse, interpersonal partner violence) are involved in the development of the self and PTSD psychopathological manifestations. Looking at a neuroscience approach, it has been proposed a nested hierarchical model of self, which identifies three neural-mental networks: (i) interoceptive; (ii) exteroceptive; (iii) mental. However, it is still unclear how the self and its related brain networks might be affected by non-relational vs relational traumatic experiences...
March 21, 2024: Molecular Psychiatry
https://read.qxmd.com/read/38509197/chemogenetic-inhibition-of-central-amygdala-crf-expressing-neurons-decreases-alcohol-intake-but-not-trauma-related-behaviors-in-a-rat-model-of-post-traumatic-stress-and-alcohol-use-disorder
#36
JOURNAL ARTICLE
Bryan Cruz, Valentina Vozella, Vittoria Borgonetti, Ryan Bullard, Paula C Bianchi, Dean Kirson, Luisa B Bertotto, Michal Bajo, Roman Vlkolinsky, Robert O Messing, Eric P Zorrilla, Marisa Roberto
Post-traumatic stress disorder (PTSD) and alcohol use disorder (AUD) are often comorbid. Few treatments exist to reduce comorbid PTSD/AUD. Elucidating the mechanisms underlying their comorbidity could reveal new avenues for therapy. Here, we employed a model of comorbid PTSD/AUD, in which rats were subjected to a stressful shock in a familiar context followed by alcohol drinking. We then examined fear overgeneralization and irritability in these rats. Familiar context stress elevated drinking, increased fear overgeneralization, increased alcohol-related aggressive signs, and elevated peripheral stress hormones...
March 21, 2024: Molecular Psychiatry
https://read.qxmd.com/read/38503931/introducing-neurofilament-light-chain-measure-in-psychiatry-current-evidence-opportunities-and-pitfalls
#37
REVIEW
Francesco Bavato, Christian Barro, Laura K Schnider, Joel Simrén, Henrik Zetterberg, Erich Seifritz, Boris B Quednow
The recent introduction of new-generation immunoassay methods allows the reliable quantification of structural brain markers in peripheral matrices. Neurofilament light chain (NfL), a neuron-specific cytoskeletal component released in extracellular matrices after neuroaxonal impairment, is considered a promising blood marker of active brain pathology. Given its sensitivity to a wide range of neuropathological alterations, NfL has been suggested for the use in clinical practice as a highly sensitive, but unspecific tool to quantify active brain pathology...
March 19, 2024: Molecular Psychiatry
https://read.qxmd.com/read/38503930/the-potential-of-baicalin-to-enhance-neuroprotection-and-mitochondrial-function-in-a-human-neuronal-cell-model
#38
JOURNAL ARTICLE
Zoe S J Liu, Trang T T Truong, Chiara C Bortolasci, Briana Spolding, Bruna Panizzutti, Courtney Swinton, Jee Hyun Kim, Damián Hernández, Srisaiyini Kidnapillai, Laura Gray, Michael Berk, Olivia M Dean, Ken Walder
Baicalin is a flavone glycoside derived from flowering plants belonging to the Scutellaria genus. Previous studies have reported baicalin's anti-inflammatory and neuroprotective properties in rodent models, indicating the potential of baicalin in neuropsychiatric disorders where alterations in numerous processes are observed. However, the extent of baicalin's therapeutic effects remains undetermined in a human cell model, more specifically, neuronal cells to mimic the brain environment in vitro. As a proof of concept, we treated C8-B4 cells (murine cell model) with three different doses of baicalin (0...
March 19, 2024: Molecular Psychiatry
https://read.qxmd.com/read/38503929/gephyrin-phosphorylation-facilitates-sexually-dimorphic-development-and-function-of-parvalbumin-interneurons-in-the-mouse-hippocampus
#39
JOURNAL ARTICLE
Benjamin F N Campbell, Natalia Cruz-Ochoa, Kanako Otomo, David Lukacsovich, Pedro Espinosa, Andrin Abegg, Wenshu Luo, Camilla Bellone, Csaba Földy, Shiva K Tyagarajan
The precise function of specialized GABAergic interneuron subtypes is required to provide appropriate synaptic inhibition for regulating principal neuron excitability and synchronization within brain circuits. Of these, parvalbumin-type (PV neuron) dysfunction is a feature of several sex-biased psychiatric and brain disorders, although, the underlying developmental mechanisms are unclear. While the transcriptional action of sex hormones generates sexual dimorphism during brain development, whether kinase signaling contributes to sex differences in PV neuron function remains unexplored...
March 19, 2024: Molecular Psychiatry
https://read.qxmd.com/read/38503928/associations-of-altered-leukocyte-ddr1-promoter-methylation-and-childhood-trauma-with-bipolar-disorder-and-suicidal-behavior-in-euthymic-patients
#40
JOURNAL ARTICLE
Beatriz Garcia-Ruiz, Esther Jiménez, Selena Aranda, Norma Verdolini, Alfonso Gutiérrez-Zotes, Cristina Sáez, Elisa Losantos, Silvia Alonso-Lana, Mar Fatjó-Vilas, Salvador Sarró, Llanos Torres, Francesco Panicalli, Caterina Del Mar Bonnin, Edith Pomarol-Clotet, Eduard Vieta, Elisabet Vilella
Altered DNA methylation (DNAm) patterns of discoidin domain receptor 1 (DDR1) have been found in the blood and brain of patients with schizophrenia (SCZ) and the brain of patients with bipolar disorder (BD). Childhood trauma (CT) is associated with changes in DNAm that in turn are related to suicidal behavior (SB) in patients with several psychiatric disorders. Here, using MassARRAY® technology, we studied 128 patients diagnosed with BD in remission and 141 healthy controls (HCs) to compare leukocyte DDR1 promoter DNAm patterns between patients and HCs and between patients with and without SB...
March 19, 2024: Molecular Psychiatry
journal
journal
32543
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.